Steve Valiquette
Stock Analyst at Barclays
(1.46)
# 3,521
Out of 5,033 analysts
158
Total ratings
45.87%
Success rate
-3.52%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7.5 → $8 | $8.77 | -8.78% | 5 | Aug 7, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.98 | +33.63% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $787.82 | -21.81% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $3.98 | +126.13% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $9.98 | -49.90% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $5.22 | +91.57% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $18.88 | +27.12% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $82.48 | +4.27% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $35.61 | +138.70% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $433.15 | -30.74% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.53 | -4.31% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $202.11 | -48.05% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $71.50 | -23.08% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.44 | -29.48% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $207.24 | -31.48% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $26.73 | -81.29% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $125.20 | -54.47% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $177.71 | -53.86% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $18.72 | -3.85% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $41.05 | -24.48% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $197.49 | +89.88% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $35.19 | -46.01% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $284.00 | +100.70% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $157.27 | -59.31% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $306.84 | +1.03% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $364.48 | +55.02% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $4.46 | +1,581.61% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $5.35 | +255.14% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.19 | +213.48% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $28.02 | +21.34% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $10.27 | +94.74% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $100.95 | +157.55% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $7.5 → $8
Current: $8.77
Upside: -8.78%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.98
Upside: +33.63%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $787.82
Upside: -21.81%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $3.98
Upside: +126.13%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $9.98
Upside: -49.90%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $5.22
Upside: +91.57%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $18.88
Upside: +27.12%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $82.48
Upside: +4.27%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $35.61
Upside: +138.70%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $433.15
Upside: -30.74%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.53
Upside: -4.31%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $202.11
Upside: -48.05%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $71.50
Upside: -23.08%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.44
Upside: -29.48%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $207.24
Upside: -31.48%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $26.73
Upside: -81.29%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $125.20
Upside: -54.47%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $177.71
Upside: -53.86%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $18.72
Upside: -3.85%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $41.05
Upside: -24.48%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $197.49
Upside: +89.88%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $35.19
Upside: -46.01%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $284.00
Upside: +100.70%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $157.27
Upside: -59.31%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $306.84
Upside: +1.03%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $364.48
Upside: +55.02%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $4.46
Upside: +1,581.61%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $5.35
Upside: +255.14%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.19
Upside: +213.48%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $28.02
Upside: +21.34%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $10.27
Upside: +94.74%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $100.95
Upside: +157.55%